Gyre Therapeutics
7.96
+0.81
+11.33%
GYRE
10-10 16:00:00(美东时间)
高
8.50
开
7.75
量
33.12万股
总市值
7.67亿
低
7.75
换
0.34%
额
268.60万
市盈TTM
184.07
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
Gyre Therapeutics(GYRE)
09-10 21:05
$Gyre Therapeutics(GYRE)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-034506 Act: 34 Size: 4 MB
网页链接
Gyre Therapeutics(GYRE)
08-27 04:15
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-032719 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
08-27 04:05
$Gyre Therapeutics(GYRE)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001140361-25-032710 Size: 11 KB
网页链接
Gyre Therapeutics(GYRE)
08-22 19:15
$Gyre Therapeutics(GYRE)$
8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001140361-25-032295 Act: 34 Size: 185 KB
网页链接
Gyre Therapeutics(GYRE)
08-12 05:15
$Gyre Therapeutics(GYRE)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-106644 Act: 34 Size: 15 MB
网页链接
Gyre Therapeutics(GYRE)
08-12 04:05
$Gyre Therapeutics(GYRE)$
8-K Current report, items 2.02, 5.02, 7.01, and 9.01 Accession Number: 0000950170-25-106525 Act: 34 Size: 681 KB
网页链接
Gyre Therapeutics(GYRE)
08-08 08:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-029693 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021789 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021793 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021792 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021791 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021790 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
06-06 18:05
$Gyre Therapeutics(GYRE)$
8-K Current report, item 5.07 Accession Number: 0001140361-25-021612 Act: 34 Size: 169 KB
网页链接
Gyre Therapeutics(GYRE)
05-30 04:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020754 Size: 7 KB
网页链接
Gyre Therapeutics(GYRE)
05-29 06:15
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020669 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
05-28 04:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020474 Size: 7 KB
网页链接
1赞
Gyre Therapeutics(GYRE)
05-24 04:55
$Gyre Therapeutics(GYRE)$
8-K Current report, items 1.01 and 9.01 Accession Number: 0001140361-25-020353 Act: 34 Size: 741 KB
网页链接
1赞
Gyre Therapeutics(GYRE)
05-24 04:45
$Gyre Therapeutics(GYRE)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001140361-25-020349 Act: 33 Size: 701 KB
网页链接
1赞
Gyre Therapeutics(GYRE)
05-23 05:35
$Gyre Therapeutics(GYRE)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001140361-25-020208 Act: 33 Size: 702 KB
网页链接
1赞
Gyre Therapeutics(GYRE)
05-23 04:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020156 Size: 7 KB
网页链接
1赞